Partner with us through the Research Study Volunteer Program, RSVP For Health
  • The Effects of Short Term Acipimox Treatment on Skeletal Muscle Phosphocreatine Recovery in Obesity.
Looking for Overweight Adults for a Clinical Research Study

If you are between the ages of 18 and 55 years and are overweight, you may qualify for a research study to evaluate the effects of a drug called acipimox on mitochondrial function.

Study involves:
• 8 outpatient visits over 7 months. 2 of the visits will last 12 hours.
• Muscle biopsy and MRI tests.
• Up to $800 compensation after completion of the study

For more information, please call Caitlin at (617) 643-4420



Massachusetts General Hospital

Harvard Medical School
Institution  –  MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator  – Hideo Makimura, MD, PhD
  
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name  – Catilin Murphy
Phone  – 6176434420

About Obesity:
Being obese increases the risk for many diseases, especially heart disease, stroke, cancer, and diabetes.

According to the Centers for Disease Control and Prevention, obesity has reached epidemic proportions. It has a far-ranging negative effect on health. Persons who are overweight or obese are at increased risk for developing many different health conditions, including heart disease, type 2 diabetes, and bone and joint disease.